SCHEMBL10477441

SCHEMBL10477441

CCOC(C)OC(=O)c1nc2cc(Cl)ccc2o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 3/20 0.43
MAPT P10636 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SENP7 Q9BQF6 2/20 0.42
LMNA P02545 2/20 0.42
FFAR2 O15552 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ALOX12 P18054 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
XDH P47989 1/20 0.42
TP53 P04637 1/20 0.42
MAOB P27338 1/20 0.41
ANO1 Q5XXA6 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP1A2 P05177 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10829015 0.82 MAOB (0.52) CASP3MAPTNPSR1SENP7LMNA
SCHEMBL11077232 0.80 CASP3 (0.44) CASP3MAPTNPSR1SENP7LMNA
SCHEMBL10829024 0.78 MAPT (0.56) CASP3MAPTNPSR1SENP7LMNA
Eclazolast SCHEMBL636302 0.77 MEN1 (0.46) CASP3MAPTNPSR1SENP7LMNA
SCHEMBL5095572 0.75 MEN1 (0.51) CASP3MAPTNPSR1SENP7LMNA
SCHEMBL27654631 0.74 MAPT (0.58) CASP3MAPTSENP7LMNAFFAR2
SCHEMBL11197714 0.74 KMT2A (0.51) MAPTNPSR1LMNAALDH1A1MEN1
SCHEMBL5517471 0.73 MAPT (0.42) CASP3MAPTNPSR1SENP7LMNA
SCHEMBL11347687 0.73 PARP3 (0.51) MAPTNPSR1LMNAMEN1KMT2A
SCHEMBL4051005 0.73 MAPT (0.42) CASP3MAPTNPSR1SENP7LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0327052-A2 Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-08-09 EP claimed
US-4831040-A (IMIDAZOLO-, THIAZOLO-, OXAZOLO-)(4,5-H)-QUINOLINE RORER PHARMACEUTICAL CORPORATION (US) 1989-05-16 US claimed
EP-0327052-A2 Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-08-09 EP disclosed
US-4831040-A (IMIDAZOLO-, THIAZOLO-, OXAZOLO-)(4,5-H)-QUINOLINE RORER PHARMACEUTICAL CORPORATION (US) 1989-05-16 US disclosed
EP-0039919-B1 BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES WITH ANTI-ALLERGIC ACTIVITY USV PHARMACEUTICAL CORPORATION (US) 1983-12-28 EP disclosed
EP-0039919-A1 Benzoxazole and benzothiazole derivatives with anti-allergic activity USV PHARMACEUTICAL CORPORATION (US) 1981-11-18 EP disclosed
US-4298742-A ANTIALLERGENS USV PHARMACEUTICAL CORPORATION (US) 1981-11-03 US disclosed